Nuwellis

Yahoo Finance • 23 days ago

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

MINNEAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces it has retained CORE IR, a leading investor... Full story

Yahoo Finance • 2 months ago

Nuwellis, Inc. Q4 2025 Earnings Call Summary

Nuwellis, Inc. Q4 2025 Earnings Call Summary - Moby Executive Narrative Management characterized 2025 as a year of deliberate repositioning rather than a continuation, focusing on strengthening the operating foundation over top-line grow... Full story

Yahoo Finance • 2 months ago

Nuwellis (NUWE) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, March 10, 2026 at 9 a.m. ET CALL PARTICIPANTS Chairman of the Board and Chief Executive Officer — John L. Erb Chief Financial Officer — Carissa Schultz Vice President, Investor Relations — L... Full story

Yahoo Finance • 5 months ago

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

MINNEAPOLIS, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, addressing the critical interplay between the heart an... Full story

Yahoo Finance • 5 months ago

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

MINNEAPOLIS, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, announced today that a leading Northeastern U.S. chil... Full story

Yahoo Finance • 6 months ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

MINNEAPOLIS, MN, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, addressing the critical interplay between the hear... Full story

Yahoo Finance • 7 months ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill children, a population with extremely limited treatment options Results highlight life-threatening gaps in pedia... Full story

Yahoo Finance • 8 months ago

Monday's after hours session: top gainers and losers

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. [postmarket] GAINERS TICKER CHANGE COMMENT WBTN [https://www.chartmill.com/stock/quote/WBTN/profile] 71.66%... Full story

Yahoo Finance • 8 months ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

MINNEAPOLIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, announced plans to introduce a new 24-hour circuit for Aquadex therapy in the United States this fall. The new circuit is designed for single-day... Full story

Yahoo Finance • 8 months ago

Nuwellis receives FDA clearance for new size of dual lumen catheter

Nuwellis, Inc. (NASDAQ:NUWE), a medical device company with a market capitalization of $2.93 million, announced Thursday that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new size of its Dual Lumen Extende... Full story

Yahoo Finance • 8 months ago

Form 8K Nuwellis Inc For: 21 August

... Full story

Yahoo Finance • 8 months ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

MINNEAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new si... Full story

Yahoo Finance • 8 months ago

Nuwellis announces non-binding letter of intent to acquire Rendiatech

Nuwellis, Inc. (NASDAQ:NUWE), a medical device company with a market capitalization of $3.3 million and annual revenue of $8.3 million, announced Tuesday that it has entered into a non-binding letter of intent to acquire Rendiatech, Ltd.,... Full story

Yahoo Finance • 8 months ago

Nuwellis signs letter of intent to acquire Rendiatech

Nuwellis (NASDAQ:NUWE [https://seekingalpha.com/symbol/NUWE]) has signed a non-binding letter of intent [https://seekingalpha.com/pr/20204874-nuwellis-signs-letter-of-intent-to-explore-acquisition-of-rendiatech-ltd-a-real-time-fluid] to ac... Full story

Yahoo Finance • 8 months ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Proposed acquisition supports strategy to drive technology expansion of fluid management offering to include continuous renal health monitoring technologies supporting the full patient journey, from early risk assessment to targeted fluid... Full story

Yahoo Finance • 9 months ago

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

MINNEAPOLIS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced that it will present at the Webull Financial Co... Full story

Yahoo Finance • 9 months ago

Nuwellis outlines Q3 recovery and strategic shift after resolving $400,000 back order

Earnings Call Insights: Nuwellis, Inc. (NUWE) Q2 2025 MANAGEMENT VIEW * John L. Erb, CEO, reported that Nuwellis entered the second quarter with an emphasis on strengthening operational discipline, commercial execution, and strategic i... Full story

Yahoo Finance • 9 months ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company dedicated to transforming care for fluid overload patients, today announced financial results for the second quar... Full story

Yahoo Finance • 9 months ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced its decision to exit international operations i... Full story

Yahoo Finance • 9 months ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

MINNEAPOLIS, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced that it will postpone its 2025 second quarter earnings release and conference call, o... Full story